Taken together, we demonstrated that endogenous KRAS mutations could be corrected by the universal pegRNA in HEK293T/17 cells, pancreatic cancer cell lines, and colon cancer cell lines. This evidence concerns the gene KRAS and pancreatic neoplasm.